BioSpace News Archive

Policy

Turning Point Therapeutics Provides Regulatory Update for Repotrectinib for the Treatment of ROS1+ Advanced NSCLC

Turning Point Therapeutics, Inc. announced receipt of positive feedback from the U.S. Food and Drug Administration at a pre-New Drug Application meeting completed within the second quarter.

July 27, 2022
·
4 min read
Business

Novocure Announces Recipients of 4th Annual AACR-Novocure Grants for Tumor Treating Fields Research Program

Novocure Announces Recipients of 4th Annual AACR-Novocure Grants for Tumor Treating Fields Research Program.

July 27, 2022
·
7 min read
Biotech Bay

Cortexyme Corporate Name Change to Quince Therapeutics to Take Effect on August 1, 2022

Cortexyme Corporate Name Change to Quince Therapeutics to Take Effect on August 1, 2022.

July 27, 2022
·
2 min read
Business

Agenus to Provide Corporate Update and Second Quarter 2022 Financial ReportConference Call on Tuesday, August 9, 2022 at 8:30 a.m. ET

Agenus (NASDAQ: AGEN) an immuno-oncology company with an extensive pipeline of therapeutics designed to activate the immune response to cancers and infections, today announced it will release its second quarter 2022 financial results before the market opens on Tuesday, August 9, 2022.

July 27, 2022
·
1 min read
BioMidwest

BAMF Health and Telix complete first total-body PET scans with Illuccix for prostate cancer imaging

The PSMA-PET[1] imaging agent Illuccix® from Telix Pharmaceuticals Limited (Telix) has been used in combination with the uEXPLORER®, a first-of-its kind total-body PET scanner from United Imaging for the first time.

July 27, 2022
·
11 min read
Deals

Mymee Acquires Breakthrough Health, Leading Digital Health Platform for Multiple Sclerosis

Mymee, a leading provider of specialized care and support for people with significant symptoms associated with autoimmune disease and long COVID, has acquired Berlin-based Breakthrough Health, the creator of the #1 mobile app Emilyn for people with multiple sclerosis (MS).

July 27, 2022
·
4 min read
Biotech Bay

Empowering Tomorrow’s Great Minds in Cancer Research: The Parker Institute for Cancer Immunotherapy Awards up to $4.5 Million to Nine Early Career Researchers; Total of Over $19 Million Awarded to Date

The Parker Institute for Cancer Immunotherapy is helping to forge a future without cancer, by investing in ’s top talent to train and empower the research leaders of tomorrow.

July 27, 2022
·
6 min read
Biotech Beach

Patient achieves HIV and blood cancer remission three decades after HIV diagnosis through stem cell transplant at City of Hope

Known as the City of Hope patient, he is the fourth patient in the world and the oldest to go into long-term remission of HIV without antiretroviral therapy for over a year after receiving stem cells from a donor with a rare genetic mutation.

July 27, 2022
·
8 min read
BioMidwest

Mercury Medical Receives EU Quality Management Medical Device (MDR) Certification

Mercury Medical recently received MDR CE Mark Certification for their CPR manual resuscitation line.

July 27, 2022
·
2 min read
BioMidwest

RemSleep Holdings Inc. Commences Trading on OTCQB

RemSleep Holdings Inc. is pleased to announce that the company’s common shares will begin trading on the OTCQB Market as of the opening of the market on , July 27, 2022.

July 27, 2022
·
3 min read